Simple jQuery Dropdowns
Please use this identifier to cite or link to this item: http://repository.li.mahidol.ac.th/dspace/handle/123456789/18414
Full metadata record
DC FieldValueLanguage
dc.contributor.authorChristoph Wenischen_US
dc.contributor.authorSornchai Looareesuwanen_US
dc.contributor.authorPolrat Wilairatanaen_US
dc.contributor.authorBernhard Parschalken_US
dc.contributor.authorSuparp Vannapannen_US
dc.contributor.authorVara Wanaratanaen_US
dc.contributor.authorWalther Wernsdorferen_US
dc.contributor.authorWolfgang Graningeren_US
dc.contributor.otherAllgemeines KrankenHaus Wienen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherUniversitat Wienen_US
dc.date.accessioned2018-07-04T08:08:05Z-
dc.date.available2018-07-04T08:08:05Z-
dc.date.issued1998-01-01en_US
dc.identifier.citationAmerican Journal of Tropical Medicine and Hygiene. Vol.58, No.3 (1998), 343-347en_US
dc.identifier.issn00029637en_US
dc.identifier.other2-s2.0-0031923048en_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0031923048&origin=inwarden_US
dc.identifier.urihttp://repository.li.mahidol.ac.th/dspace/handle/123456789/18414-
dc.description.abstractThe effect of pentoxifylline (PTX) was tested for its capacity to modulate cytokine responses during therapy of severe Plasmodium falciparum malaria in a placebo-controlled, randomized study in 45 adult patients in Bangkok, Thailand. The patients received standard antimalarial treatment with artesunate (120 mg intravenously given immediately, then 60 mg every 12 hr for a total dose of 600 mg). The patients received either low-dose PTX (20 mg/kg/day, n = 15), high-dose PTX (40 mg/kg/day, n = 15), or placebo (n = 15) as continuous infusion for the first three days of antimalarial treatment. Tumor necrosis factor (TNF) and interleukin-6 (IL-6) plasma levels were markedly elevated in all patients prior to treatment. After 6 hr of high- dose PTX treatment, TNF and IL-6 levels significantly decreased while an increase in TNF and IL-6 levels was seen after 6 hr of low-dose PTX or placebo treatment (P < 0.01). After 12 and 24 hr of high-dose PTX infusion, TNF-receptor plasma concentrations were lower than in low-dose PTX- or placebo-treated patients (P < 0.01), whereas no differences between the groups with regard to IL6 receptor levels were observed. We conclude that 40 mg/kg/day of PTX reduces plasma levels of TNF IL-6, and TNF-receptor in patients with severe malaria. Whether this reduction improves clinical outcome remains to be determined.en_US
dc.rightsMahidol Universityen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0031923048&origin=inwarden_US
dc.subjectImmunology and Microbiologyen_US
dc.subjectMedicineen_US
dc.titleEffect of pentoxifylline on cytokine patterns in the therapy of complicated Plasmodium falciparum malariaen_US
dc.typeArticleen_US
dc.rights.holderSCOPUSen_US
dc.identifier.doi10.4269/ajtmh.1998.58.343en_US
Appears in Collections:Scopus 1991-2000

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.